ICD-10 R76.89 is officially defined as "Other specified abnormal immunological findings in serum." code R76.89 is referenced in 3 tracked payer policy changes from Independence Blue Cross and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code R76.89 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Independence Blue Cross reissued policy 07.02.22j for EGD and ERCP procedures, replacing broad ICD-10 diagnosis codes with more specific anatomical pain codes and marking them as not medically necessary. This creates tighter claim review criteria for abdominal pain presentations that do not meet defined medical necessity thresholds.
Independence Blue Cross reissued policy 07.02.22j on EGD and ERCP procedures, effective 10/01/2025, with granular ICD-10 code refinements. Specific abdominal and flank pain diagnosis codes (R10.21, R10.22, R10.23, R10.24, R10.85, R10.8A1-A3, R10.8A9, R10.A1-A3, R76.89) are now classified as NOT medically necessary for EGD, replacing broader codes (R10.2, R76.8). Billing teams must update claim denial logic and prior authorization systems to deny EGD claims when these specific diagnosis codes are the sole or primary justification.
Treatment of Lyme disease consists of oral antibiotics except for neuroborreliosis, Lyme carditis and Lyme arthritis. A 2- to 4-week course of IV antibiotics may be considered medically necessary for neuroborreliosis with objective neurologic complications of documented Lyme disease, and a single 2- to 4-week IV course may be considered for Lyme carditis or for the small subset of well-documented Lyme arthritis that is severe enough to need the rapid response of IV antibiotics. IV antibiotic therapy is considered investigational for conditions such as chronic fatigue syndrome or fibromyalgia without objective evidence of Lyme disease, post-Lyme syndrome, and repeat or prolonged courses longer than 4 weeks.
Watch R76.89
Get one email when a payer policy names R76.89, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.